Page last updated: 2024-09-04

levofloxacin and Escherichia coli Infections

levofloxacin has been researched along with Escherichia coli Infections in 85 studies

*Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI. [MeSH]

Research

Studies (85)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (1.18)	18.2507
2000's	30 (35.29)	29.6817
2010's	48 (56.47)	24.3611
2020's	6 (7.06)	2.80

Authors

Authors	Studies
Frigola, J; García-Granda, S; Gómez-Gomar, A; Ortega, E; Torrens, A; Vañó, D	1
Barth, AL; Castanheira, M; Gales, AC; Nicoletti, AG; Pereira, AS; Pignatari, AC	1
Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K	1
Arakawa, Y; Suzuki, S; Wachino, J; Yamane, K	1
Baudry, PJ; DeCorby, M; Hoban, DJ; Mataseje, L; Mulvey, MR; Nichol, K; Zhanel, GG	1
Cauda, R; D'Inzeo, T; De Pascale, G; Fadda, G; Fiori, B; Leone, F; Rossi, M; Sali, M; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M	1
Cattoir, V; Nordmann, P; Poirel, L	1
Blango, MG; Mulvey, MA	1
Carmeli, Y; Chmelnitsky, I; Goren, MG; Navon-Venezia, S	1
Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ	1
Al-Trawneh, SA; Alfieri, RR; Cavazzoni, A; El-Abadelah, MM; Incerti, M; Kamal, MR; Petronini, PG; Vicini, P; Zahra, JA; Zani, F	1
Minami, K; Nishihara, M; Oda, K; Suzuki, K; Uchiyama, K; Ukimura, A; Yamada, T	1
Al Atbee, MYN; Jalil, MB	1
Chen, J; Liu, W; Zhao, F	1
Dobashi, M; Ikeda, M; Ishii, J; Koguchi, D; Murakami, Y	1
Dong, H; He, S; Hu, G; Li, Q; Liu, X; Mu, X	1
Braconi, L; Capitanio, M; Casalone, E; Dei, S; Gardini, L; Pavone, FS; Teodori, E; Vignolini, T	1
Conigliaro, A; Grodin, L; Lee, SY; Rose, M; Sinert, R	1
Monogue, ML; Nicolau, DP	1
Connor, P; Danboise, B; Fraser, J; Gutierrez, RL; Hulseberg, C; Hutley, EJ; Lalani, T; Porter, CK; Riddle, MS; Simons, MP; Swierczewski, B; Tribble, DR	1
Judd, WR; Ratliff, PD; Wang, SS	1
Hwang, GY; Jhang, J; Uh, Y; Wang, HY; Yoo, G; Yoon, KJ	1
Chen, WH; Li, RB; Shen, LJ; Wang, XL; Wang, YM; Wen, JL; Wen, XF	1
Arcos, D; Aznar, E; García-Fernández, A; Gómez-Cerezo, N; Martínez-Máñez, R; Polo, L; Vallet-Regí, M; Vivancos, JL	1
Kuninaga, N; Matsuura, H; Sue, M; Takahara, M	1
Ben Salem, C; Brahim, A; Fathallah, N; Ouni, B; Slim, R	1
Chen, PL; Hung, YP; Ko, WC; Lee, NY; Li, CW; Li, MC; Liu, CC; Syue, LS; Tang, HJ; Tsai, PF	1
Everhart, RM; Knepper, BC; Price, CS; Ryan, PP	1
Hashimoto, J; Hirose, T; Hiyama, Y; Hotta, H; Ichihara, K; Itoh, N; Kunishima, Y; Masumori, N; Matsukawa, M; Tachiki, H; Taguchi, K; Takahashi, S; Takeyama, K; Uehara, T; Yanase, M	1
Nishiura, H; Terahara, F	1
Briales, A; Díaz-de-Alba, P; Docobo-Pérez, F; Domínguez-Herrera, J; López-Rojas, R; Pachón, J; Pascual, A; Pichardo, C; Rodríguez-Baño, J; Rodríguez-Martínez, JM; Velasco, C	1
Bayne, CE; Davis, WA; Engel, JD; Rothstein, CP	1
Cui, J; Ni, W; Song, X	1
Akashi, K; Aoki, T; Chong, Y; Ito, Y; Kamimura, T; Miyamoto, T; Shimoda, S; Shimono, N; Yakushiji, H	1
Fleming, VH; Southwood, R; White, BP	1
Meizoso-Latova, T; Morales-Conejo, M; Moreno-Cuerda, VJ; Ruiz-Galiana, J	1
Grossman, TH; Kerstein, KO; O'Brien, W; Sutcliffe, JA	1
Chan, S; Coulter, MM; Di Pentima, MC; Hossain, J; Rosé, L	1
Al-Salamah, T; Hayes, BD; Heil, EL; Hines, MC; Johnson, JK; Mallemat, H; Winters, ME; Witting, MD	1
Aksaray, S; Avcıküçük, H; Başustaoğlu, A; Kaşkatepe, B; Süzük, S	1
Chen, Y; Ding, X; Gu, H; Guo, M; Guo, X; Wang, Y; Zhang, Y	1
Li, Y; Lyu, Y; Xue, F; Zheng, B; Zhu, SN	1
Bliss, CA; Cloutier, D; Hershberger, E; Huntington, JA; Kaye, KS; Miller, B; Paterson, DL; Popejoy, MW; Steenbergen, JN; Umeh, O	1
Al-Hasan, MN; Albrecht, H; Bookstaver, PB; Justo, JA; Kohn, J; Shah, A	1
Frenck, RW; Johnston, JR; Monteville, MR; Putnam, SD; Riddle, MS; Rockabrand, DM; Sanders, JW; Tribble, DR; Ulukan, S	1
Abrahamian, FM; Krishnadasan, A; Moran, GJ; Stamm, WE; Talan, DA	1
Burman, WJ; Everhart, RM; Johnson, L; MacKenzie, TD; Mehler, PS; Price, CS; Rome, M; Rozwadowski, J; Sabel, A	1
Alişkan, H; Güçlü, M; Husamettin, E; Serin, E; Yakar, T	1
Kim, EC; Kim, MS	1
De Vecchi, E; Drago, L; Mattina, R; Nicola, L	1
Fujishima, Y; Kato, R; Matsuura, T; Obara, W; Sato, K; Shimaya, R; Suzuki, Y; Tokiwa, S	1
Arakawa, S; Fujisawa, M; Kawabata, M; Kinoshita, S; Nakano, Y; Nishimura, K; Shigemura, K; Shirakawa, T; Tanaka, K; Yasufuku, T	1
Aracil, B; Campos, J; Cuevas, O; de Abajo, F; García-Cobos, S; Lázaro, E; Ortega, A; Oteo, J	1
Deguchi, T; Matsumoto, T; Seike, K; Yasuda, M	1
Naber, KG; Roscher, K; Wagenlehner, F	1
Bartoletti, R; Boddi, V; Cai, T; Malossini, G; Mazzoli, S; Meacci, F; Mondaini, N	1
Baba, S; Fujita, T; Iwamura, M; Kimura, M; Kurosaka, S; Matsumoto, K; Minamida, S; Satoh, T; Tabata, K; Tsumura, H	1
Hu, M; Ledesma, KR; Singh, R; Swick, MC; Tam, VH; Yang, Z; Zechiedrich, L	1
Fujii, N; Kuwahara, O; Ohkoshi, Y; Okabayashi, T; Okubo, T; Sato, T; Tamura, Y; Yokota, S	1
Amaral, AL; Claro, V; Cunha-Silva, L; de Castro, B; Feio, MJ; Gameiro, P; Pereira, E; Pereira, JL; Sousa, I	1
Hsueh, PR; Lee, YJ; Lin, YC; Liu, HY; Wu, HH	1
Guo, YL; Jin, FS; Liu, DM; Shen, ZJ; Sun, YH; Zhang, ZC	1
Nakamura-Uchiyama, F; Ohnishi, K	1
He, HX; He, Y; Qin, GD; Xiao, MZ; Yang, J; Zeng, Y; Zhou, YD	1
Hiramatsu, K; Hirata, N; Kadota, J; Kishi, K; Murakami, J; Nasu, M; Shibata, T; Yamasaki, T	1
Chan, KW; Kung, WH; Li, R; Tam, VK	1
Cho, YH; Choi, YJ; Hwang, TK; Kim, JC; Lee, SJ; Seo, SI; SW, SW	1
Bouros, DE; Kottakis, I; Liapakis, IE; Light, RW; Pitiakoudis, MS; Simopoulos, CE; Tsatsakis, AM; Tzatzarakis, MN; Ypsilantis, P	1
Hermsen, ED; Hovde, LB; Rodvold, KA; Rotschafer, JC; Sprandel, KA	1
Dib, C; Durand, C; Moniot-Ville, N; Weber, P	1
Chen, SW; Shen, ZJ; Wang, H; Zhao, JP; Zhou, XL	1
Bilker, WB; Fishman, NO; Lautenbach, E; Mao, X; Metlay, JP; Nachamkin, I; Tolomeo, P	1
Cars, O; Odenholt, I	1
Cambau, E; Cattoir, V; Denamur, E; Lascols, C; Legrand, P; Lesprit, P; Soussy, CJ	1
Drago, L; Esposito, S; Leone, S; Marchetti, F; Marvaso, A; Noviello, S	1
Armstrong, A; Baqar, S; Bodhidatta, L; Faix, DJ; Fox, A; Hshieh, P; Lawler, JV; Lebron, C; Lewis, M; Maley, EA; Mason, C; Nayak, G; Pang, LW; Pitarangsi, C; Sanders, JW; Scott, DA; Tribble, DR	1
Gualco, L; Marchese, A; Schito, AM; Schito, GC	1
Dib-Smahi, C; Lascols, C; Soussy, CJ	1
Bryski, L; Duckworth, H; Harding, G; Nicolle, L; Sitar, D; Zhanel, G	1
Fujisawa, M; Miura, T; Nakano, Y; Shigemura, K; Takenaka, A; Tanaka, K	1
Amazutsumi, K; Harada, T; Kawamura, H; Koyama, Y; Matsuda, T; Mikami, O; Murota, T; Ohara, T; Uchida, J	1
Fujii, N; Hayashi, S; Isogai, E; Isogai, H; Kimura, K; Kubota, T; Ohtani, T; Sato, K	1
Hayashi, S; Hirose, K; Isogai, E; Isogai, H; Oguma, K	1
Fujii, N; Hayashi, S; Hirose, K; Isogai, E; Isogai, H; Kimura, K; Kubota, T; Oguma, K; Takeshi, K	1
Bahar, IH; Baskin, H; Doğan, Y; Yuluğ, N	1

Reviews

3 review(s) available for levofloxacin and Escherichia coli Infections

Article	Year
Seminal vesicle abscess following prostate biopsy requiring transgluteal percutaneous drainage. The Canadian journal of urology, 2013, Volume: 20, Issue:3 Topics: Abscess; Aged; Anti-Bacterial Agents; Buttocks; Ceftriaxone; Drainage; Escherichia coli; Escherichia coli Infections; Humans; Image-Guided Biopsy; Levofloxacin; Male; Nitrofurantoin; Prostate; Seminal Vesicles; Treatment Outcome; Ultrasound, High-Intensity Focused, Transrectal	2013
Renal parenchymal malacoplakia: a rare cause of ARF with a review of recent literature. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003, Volume: 41, Issue:6 Topics: Acute Kidney Injury; Aged; Biopsy, Needle; Cefuroxime; Diagnosis, Differential; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Inclusion Bodies; Kidney; Kidney Diseases; Levofloxacin; Malacoplakia; Nephritis, Interstitial; Ofloxacin; Urinary Tract Infections	2003
Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature. International journal of urology : official journal of the Japanese Urological Association, 2008, Volume: 15, Issue:5 Topics: Aged; Anti-Bacterial Agents; Biopsy; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostate; Rectum; Sepsis; Ultrasonography	2008

Trials

7 trial(s) available for levofloxacin and Escherichia coli Infections

Article	Year
Trial Evaluating Ambulatory Therapy of Travelers' Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Nov-29, Volume: 65, Issue:12 Topics: Acute Disease; Adult; Afghanistan; Anti-Bacterial Agents; Azithromycin; Diarrhea; Djibouti; Double-Blind Method; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Honduras; Humans; Kenya; Levofloxacin; Loperamide; Male; Military Personnel; Travel; Treatment Outcome	2017
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials. The Journal of antimicrobial chemotherapy, 2017, Volume: 72, Issue:1 Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Double-Blind Method; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Metronidazole; Middle Aged; Penicillanic Acid; Tazobactam; Thienamycins; Treatment Outcome; Urinary Tract Infections; Young Adult	2017
Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Volume: 45, Issue:3 Topics: Adult; Azithromycin; Campylobacter Infections; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Escherichia coli Infections; Feces; Female; Humans; Levofloxacin; Loperamide; Male; Military Personnel; Nausea; Ofloxacin; Salmonella Infections; Time Factors; Travel; Turkey; United States	2007
Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients. Asian journal of andrology, 2012, Volume: 14, Issue:6 Topics: Adult; Anti-Bacterial Agents; Asian People; Ciprofloxacin; Escherichia coli Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome	2012
A pilot study on prevention of catheter-related urinary tract infections with fluoroquinolones. Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:5 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteriuria; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pilot Projects; Placebos; Pyuria; Single-Blind Method; Treatment Outcome; Urinary Catheterization; Urinary Tract Infections	2006
Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Feb-01, Volume: 44, Issue:3 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Campylobacter Infections; Campylobacter jejuni; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Bacterial; Dysentery; Escherichia coli Infections; Female; Humans; Levofloxacin; Male; Military Personnel; Ofloxacin; Salmonella Infections; Thailand	2007
[Efficacy of single-dose therapy with levofloxacin for acute cystitis: comparison to three-day therapy]. Hinyokika kiyo. Acta urologica Japonica, 2000, Volume: 46, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Child; Cystitis; Drug Administration Schedule; Escherichia coli Infections; Female; Humans; Levofloxacin; Middle Aged; Ofloxacin; Treatment Outcome	2000

Other Studies

75 other study(ies) available for levofloxacin and Escherichia coli Infections

Article	Year
7-Azetidinylquinolones as antibacterial agents. 3. Synthesis, properties and structure-activity relationships of the stereoisomers containing a 7-(3-amino-2-methyl-1-azetidinyl) moiety. Journal of medicinal chemistry, 1995, Mar-31, Volume: 38, Issue:7 Topics: Animals; Anti-Bacterial Agents; Azetidinecarboxylic Acid; Chemical Phenomena; Chemistry, Physical; Crystallography, X-Ray; Escherichia coli Infections; Mice; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas Infections; Quinolones; Staphylococcal Infections; Stereoisomerism; Structure-Activity Relationship	1995
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Integrons; Latin America; Molecular Sequence Data; Plasmids	2007
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9 Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents	2007
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Plasmids; Prevalence	2008
Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5 Topics: Bacterial Proteins; beta-Lactamases; Canada; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Gentamicins; Humans; Intensive Care Units; Microbial Sensitivity Tests	2008
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Risk Factors; Treatment Failure	2008
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids	2008
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium	2010
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Academic Medical Centers; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Israel; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Time Factors	2010
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7 Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae	2010
Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents. Bioorganic & medicinal chemistry, 2010, Aug-15, Volume: 18, Issue:16 Topics: Anti-Bacterial Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Line; Cell Line, Tumor; DNA Gyrase; DNA Topoisomerase IV; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Topoisomerase II Inhibitors	2010
Probability of target attainment of oral antimicrobials for Escherichia coli and Klebsiella pneumoniae based on Monte Carlo simulations. Diagnostic microbiology and infectious disease, 2022, Volume: 103, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalexin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Monte Carlo Method; Probability	2022
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections. Journal of clinical laboratory analysis, 2022, Volume: 36, Issue:9 Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2022
Analysis of drug resistance genes of integrons in clinical isolates of Escherichia coli from elderly bloodstream infections. Cellular and molecular biology (Noisy-le-Grand, France), 2022, Jun-30, Volume: 68, Issue:6 Topics: Aged; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefoxitin; Clavulanic Acid; Drug Resistance; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Integrons; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Sepsis; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination	2022
Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study. BMC urology, 2020, Apr-06, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Cefaclor; Cefazolin; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Fosfomycin; Humans; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Proteus Infections; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult	2020
Comparison of the Gut Microbiota Between Frontiers in cellular and infection microbiology, 2020, Volume: 10 Topics: Animals; Drugs, Chinese Herbal; Escherichia coli; Escherichia coli Infections; Gastrointestinal Microbiome; Levofloxacin; Pulsatilla; Rats	2020
1-benzyl-1,4-diazepane reduces the efflux of resistance-nodulation-cell division pumps in Future microbiology, 2020, Volume: 15 Topics: Anti-Bacterial Agents; Azepines; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Levofloxacin; Lipoproteins; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins	2020
Comparison of UTI antibiograms stratified by ED patient disposition. The American journal of emergency medicine, 2017, Volume: 35, Issue:9 Topics: Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Emergency Service, Hospital; Escherichia coli; Escherichia coli Infections; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections	2017
Translational Efficacy of Humanized Exposures of Cefepime, Ertapenem, and Levofloxacin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Complicated Urinary Tract Infection. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:11 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Disease Models, Animal; Ertapenem; Escherichia coli Infections; Female; Humans; Levofloxacin; Mice, Inbred ICR; Microbial Sensitivity Tests; Urinary Tract Infections; Uropathogenic Escherichia coli	2017
Retrospective review of ceftriaxone versus levofloxacin for treatment of E. coli urinary tract infections. International journal of clinical pharmacy, 2018, Volume: 40, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cohort Studies; Escherichia coli; Escherichia coli Infections; Female; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Urinary Tract Infections	2018
NDM-5 and OXA-48 Co-producing Uropathogenic Escherichia coli Isolate: First Case in Korea. Annals of laboratory medicine, 2018, Volume: 38, Issue:3 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Levofloxacin; Microbial Sensitivity Tests; Uropathogenic Escherichia coli	2018
[Cefoxitin plus levofloxacin for prevention of severe infection after transrectal prostate biopsy]. Zhonghua nan ke xue = National journal of andrology, 2018, Volume: 24, Issue:4 Topics: Aged; Anti-Bacterial Agents; Biopsy; Cefoxitin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Male; Middle Aged; Postoperative Complications; Prostate; Retrospective Studies	2018
Mesoporous Bioactive Glasses Equipped with Stimuli-Responsive Molecular Gates for Controlled Delivery of Levofloxacin against Bacteria. Chemistry (Weinheim an der Bergstrasse, Germany), 2018, Dec-17, Volume: 24, Issue:71 Topics: Adenosine Triphosphate; Anti-Bacterial Agents; Bone Substitutes; Cell Line; Ceramics; Delayed-Action Preparations; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Polyamines; Porosity	2018
Escherichia coli rib osteomyelitis. QJM : monthly journal of the Association of Physicians, 2019, Jan-01, Volume: 112, Issue:1 Topics: Aged; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Male; Osteomyelitis; Ribs; Tomography, X-Ray Computed	2019
Anaphylactic shock secondary to oral ofloxacin administration with cross-reactivity to levofloxacin and ciprofloxacin. Therapie, 2018, Volume: 73, Issue:6 Topics: Administration, Oral; Adolescent; Anaphylaxis; Ciprofloxacin; Cross Reactions; Drug Hypersensitivity; Escherichia coli Infections; Female; Humans; Levofloxacin; Ofloxacin; Skin Tests; Urinary Tract Infections	2018
Bloodstream infections in hospitalized adults with dengue fever: Clinical characteristics and recommended empirical therapy. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2019, Volume: 52, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Candidemia; Cefepime; Coinfection; Dengue; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Hospitals; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Staphylococcal Infections; Streptococcus; Taiwan	2019
Antimicrobial resistance patterns in urinary E. coli isolates after a change in a single center's guidelines for uncomplicated cystitis in ambulatory settings. Infection control and hospital epidemiology, 2019, Volume: 40, Issue:5 Topics: Ambulatory Care; Anti-Infective Agents, Urinary; Case-Control Studies; Colorado; Cystitis; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Humans; Levofloxacin; Nitrofurantoin; Practice Guidelines as Topic	2019
Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli. International journal of urology : official journal of the Japanese Urological Association, 2019, Volume: 26, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Image-Guided Biopsy; Japan; Levofloxacin; Logistic Models; Male; Microbial Sensitivity Tests; Prospective Studies; Prostate; Quinolones; Rectum; Treatment Outcome; Ultrasonography, Interventional	2019
Fluoroquinolone consumption and Escherichia coli resistance in Japan: an ecological study. BMC public health, 2019, Apr-23, Volume: 19, Issue:1 Topics: Anti-Bacterial Agents; Cross Infection; Databases, Pharmaceutical; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Geography; Humans; Japan; Levofloxacin; Microbial Sensitivity Tests	2019
Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83Leu. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:7 Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Disease Models, Animal; DNA Gyrase; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Levofloxacin; Mice; Mice, Inbred C57BL; Mutant Proteins; Pneumonia, Bacterial; Treatment Outcome	2013
Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2014, Volume: 33, Issue:3 Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Levofloxacin; Microbial Sensitivity Tests; Rabbits; Soft Tissue Infections	2014
Clinical impact of fluoroquinolone-resistant Escherichia coli in the fecal flora of hematological patients with neutropenia and levofloxacin prophylaxis. PloS one, 2014, Volume: 9, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Febrile Neutropenia; Feces; Female; Hematologic Neoplasms; Host-Pathogen Interactions; Humans; Levofloxacin; Male; Middle Aged; Prospective Studies; Treatment Outcome	2014
Resistance of Escherichia coli urinary isolates in ED-treated patients from a community hospital. The American journal of emergency medicine, 2014, Volume: 32, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Bacterial; Emergency Service, Hospital; Escherichia coli Infections; Female; Hospitals, Community; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult	2014
[Xanthogranulomatous pyelonephritis with cutaneous fistula and a right flank mass]. Medicina clinica, 2015, Jun-08, Volume: 144, Issue:11 Topics: Aged, 80 and over; Anti-Bacterial Agents; Chronic Disease; Cutaneous Fistula; Drainage; Escherichia coli Infections; Female; Humans; Kidney Calculi; Levofloxacin; Pyelonephritis, Xanthogranulomatous; Radiography; Urinary Fistula	2015
Eravacycline (TP-434) is active in vitro against biofilms formed by uropathogenic Escherichia coli. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:4 Topics: Anti-Bacterial Agents; Biofilms; Colistin; Colony Count, Microbial; Escherichia coli Infections; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Tetracyclines; Thienamycins; Urinary Tract Infections; Uropathogenic Escherichia coli	2015
Trends of fluoroquinolone-resistant Escherichia coli amongst urinary isolates in children: a 10 year surveillance study. Journal of medical microbiology, 2015, Volume: 64, Issue:7 Topics: Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Microbial Sensitivity Tests; Urinary Tract Infections	2015
Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram. The Journal of emergency medicine, 2015, Volume: 49, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Emergency Service, Hospital; Escherichia coli; Escherichia coli Infections; Female; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2015
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST]. Mikrobiyoloji bulteni, 2015, Volume: 49, Issue:4 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; European Union; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Reference Standards; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli	2015
Antibiotic-loaded, silver core-embedded mesoporous silica nanovehicles as a synergistic antibacterial agent for the treatment of drug-resistant infections. Biomaterials, 2016, Volume: 101 Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Mice, Inbred BALB C; Nanocapsules; Peritonitis; Silicon Dioxide; Silver	2016
Changes in minimum inhibitory concentration of levofloxacin for Escherichia coli strains isolated from urine samples in mainland China, 2004 to 2014. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2017, Volume: 50, Issue:3 Topics: Anti-Bacterial Agents; China; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections; Urine	2017
Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Pyelonephritis; Urinary Tract Infections	2017
Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Nov-01, Volume: 47, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Emergencies; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Levofloxacin; Middle Aged; Ofloxacin; Pyelonephritis; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; United States	2008
Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. The American journal of medicine, 2008, Volume: 121, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Levofloxacin; Middle Aged; Ofloxacin; Urinary Tract Infections	2008
A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis. Digestive diseases and sciences, 2010, Volume: 55, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime; Cefotaxime; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Leukocyte Count; Levofloxacin; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged; Neutrophils; Ofloxacin; Peritonitis; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections	2010
Bilateral acanthamoeba keratitis after orthokeratology. Cornea, 2010, Volume: 29, Issue:6 Topics: Acanthamoeba Keratitis; Antiprotozoal Agents; Biguanides; Drug Therapy, Combination; Escherichia coli Infections; Female; Functional Laterality; Humans; Levofloxacin; Microscopy, Phase-Contrast; Ofloxacin; Orthokeratologic Procedures; Tobramycin; Visual Acuity; Young Adult	2010
In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations. BMC microbiology, 2010, Apr-21, Volume: 10 Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Dioxolanes; DNA Gyrase; DNA Mutational Analysis; DNA Topoisomerase IV; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Klebsiella; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Piperazines; Respiratory Tract Infections; Selection, Genetic; Urinary Tract Infections	2010
[Septic shock due to fluoroquinolone-resistant Escherichia coli after trans-rectal prostate needle biopsy]. Hinyokika kiyo. Acta urologica Japonica, 2010, Volume: 56, Issue:8 Topics: Biopsy, Needle; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Postoperative Complications; Rectum; Shock, Septic	2010
Risk factors and mechanisms of fluoroquinolone resistance in 156 Escherichia coli strains clinically isolated from urinary tract infections. Scandinavian journal of infectious diseases, 2011, Volume: 43, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Ofloxacin; Risk Factors; Sequence Analysis, DNA; Urinary Tract Infections	2011
Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Aza Compounds; Bacteremia; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hospitals; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Spain; Young Adult	2011
Evaluation by Monte Carlo simulation of levofloxacin dosing for complicated urinary tract infections caused by Escherichia coli or Pseudomonas aeruginosa. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:5 Topics: Anti-Bacterial Agents; Area Under Curve; Computer Simulation; Databases, Factual; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Models, Statistical; Monte Carlo Method; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections	2011
[Practice management of chronic bacterial prostatitis with levofloxacin]. Aktuelle Urologie, 2011, Volume: 42, Issue:3 Topics: Adult; Aged; Anti-Infective Agents, Urinary; Bacterial Infections; Chronic Disease; Escherichia coli Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Prostatitis; Recurrence; Staphylococcal Infections	2011
Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis. Journal of microbiology (Seoul, Korea), 2011, Volume: 49, Issue:3 Topics: Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Prostatitis; Young Adult	2011
Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy. Urology, 2011, Volume: 78, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Needle; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Humans; Incidence; Levofloxacin; Male; Middle Aged; Ofloxacin; Prevalence; Prostate; Prostatitis; Rectum	2011
Temporal interplay between efflux pumps and target mutations in development of antibiotic resistance in Escherichia coli. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:4 Topics: Anti-Bacterial Agents; Area Under Curve; Culture Media; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Deletion; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Polymerase Chain Reaction; Quinolones; Real-Time Polymerase Chain Reaction	2012
Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan. Chemotherapy, 2012, Volume: 58, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Child; Child, Preschool; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Japan; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prevalence; Young Adult	2012
Synthesis, characterization and antibacterial studies of a copper(II) levofloxacin ternary complex. Journal of inorganic biochemistry, 2012, Volume: 110 Topics: Anti-Bacterial Agents; Copper; Escherichia coli; Escherichia coli Infections; Levofloxacin; Ofloxacin	2012
Correlation between levofloxacin consumption and the incidence of nosocomial infections due to fluoroquinolone-resistant Escherichia coli. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:3 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2016
Does levofloxacin induce hemolytic uremic syndrome in patients infected with verotoxin-producing Escherichia coli O157 infections? Japanese journal of infectious diseases, 2012, Volume: 65, Issue:5 Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Colitis; Escherichia coli Infections; Escherichia coli O157; Female; Hemolytic-Uremic Syndrome; Humans; Japan; Levofloxacin; Male; Middle Aged; Ofloxacin; Retrospective Studies; Risk Factors; Shiga Toxins	2012
Tamsulosin alters levofloxacin pharmacokinetics in prostates derived from rats with acute bacterial prostatitis. Asian journal of andrology, 2013, Volume: 15, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Anti-Bacterial Agents; Drug Interactions; Escherichia coli Infections; Kidney; Levofloxacin; Liver; Male; Ofloxacin; Prostate; Prostatitis; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin	2013
Treatment with rokitamycin suppresses the lethality in a murine model of Escherichia coli O157:H7 infection. International journal of antimicrobial agents, 2003, Volume: 21, Issue:5 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Colony Count, Microbial; Disease Models, Animal; Escherichia coli Infections; Escherichia coli O157; Feces; Levofloxacin; Male; Mice; Mice, Inbred C3H; Miocamycin; Ofloxacin; Survival Analysis	2003
Effects of androgen deprivation on chronic bacterial prostatitis in a rat model. International journal of urology : official journal of the Japanese Urological Association, 2003, Volume: 10, Issue:9 Topics: Androgen Antagonists; Animals; Anti-Infective Agents, Urinary; Castration; Chronic Disease; Enzyme Inhibitors; Escherichia coli Infections; Estradiol; Estrogens; Finasteride; Levofloxacin; Male; Models, Animal; Ofloxacin; Prostatitis; Random Allocation; Rats; Rats, Wistar; Testosterone	2003
Penetration of newer quinolones in the empyema fluid. The European respiratory journal, 2004, Volume: 24, Issue:3 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Empyema, Pleural; Escherichia coli Infections; Fluoroquinolones; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Pleural Effusion; Quinolines; Rabbits	2004
Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:2 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Chromatography, High Pressure Liquid; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Half-Life; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Ofloxacin; Quinolines	2005
[Evaluation of levofloxacin susceptibility against strains isolated from lower urinary tract infections in the community]. Pathologie-biologie, 2005, Volume: 53, Issue:2 Topics: Anti-Infective Agents, Urinary; Bacterial Infections; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Urinary Tract Infections	2005
Life-threatening meningitis resulting from transrectal prostate biopsy. Asian journal of andrology, 2005, Volume: 7, Issue:4 Topics: Adenocarcinoma; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Biopsy; Escherichia coli Infections; Humans; Levofloxacin; Male; Meningitis; Metronidazole; Ofloxacin; Prostatic Neoplasms; Ultrasound, High-Intensity Focused, Transrectal	2005
Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative. The Journal of infectious diseases, 2006, Jul-01, Volume: 194, Issue:1 Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Genotype; Hospitals; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Ofloxacin; Phenotype; Population Surveillance; Solvents	2006
Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5 Topics: Animals; Anti-Infective Agents; Area Under Curve; Aza Compounds; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Horses; Humans; Injections, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pneumococcal Infections; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae	2006
In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5 Topics: Aged; Anti-Bacterial Agents; Bacteremia; DNA Topoisomerases; Drug Resistance; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Male; Nalidixic Acid; Ofloxacin	2006
In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance. International journal of antimicrobial agents, 2007, Volume: 29, Issue:6 Topics: Anti-Infective Agents, Urinary; Bacterial Adhesion; Ciprofloxacin; Dioxolanes; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Hemolysin Proteins; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Quinolones; Ultraviolet Rays; Urinary Tract Infections	2007
[In vitro activity of levofloxacin against Escherichia coli strains in acute pyelonephritis, in France in 2005]. Medecine et maladies infectieuses, 2007, Volume: 37, Issue:11 Topics: Acute Disease; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; France; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pyelonephritis	2007
Pharmacokinetics/pharmacodynamics of levofloxacin 750 mg once daily in young women with acute uncomplicated pyelonephritis. International journal of antimicrobial agents, 2008, Volume: 31, Issue:3 Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Area Under Curve; Escherichia coli Infections; Female; Humans; Levofloxacin; Ofloxacin; Pyelonephritis; Serum; Time Factors; Urine	2008
Effect of antibiotics, levofloxacin and fosfomycin, on a mouse model with Escherichia coli O157 infection. Microbiology and immunology, 2000, Volume: 44, Issue:2 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Diarrhea; Disease Models, Animal; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Germ-Free Life; Humans; Levofloxacin; Mice; Ofloxacin; Shiga Toxins; Treatment Outcome	2000
In vivo synergy between green tea extract and levofloxacin against enterohemorrhagic Escherichia coli O157 infection. Current microbiology, 2001, Volume: 42, Issue:4 Topics: Animals; Anti-Infective Agents; Catechin; Colony Count, Microbial; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Escherichia coli Infections; Escherichia coli O157; Feces; Female; Germ-Free Life; Levofloxacin; Male; Mice; Mice, Inbred ICR; Ofloxacin; Plant Extracts; Shiga Toxin; Tea	2001
Therapeutic effect of anti-TNF-alpha antibody and levofloxacin (LVFX) in a mouse model of enterohemorrhagic Escherichia coli O157 infection. Comparative immunology, microbiology and infectious diseases, 2001, Volume: 24, Issue:4 Topics: Animals; Anti-Infective Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Disease Models, Animal; Escherichia coli Infections; Escherichia coli O157; Female; Germ-Free Life; Immunoglobulin G; Kidney; Levofloxacin; Male; Mice; Ofloxacin; Shiga Toxin; Survival Analysis; Time Factors; Tumor Necrosis Factor-alpha	2001
Effect of subminimal inhibitory concentrations of three fluoroquinolones on adherence of uropathogenic strains of Escherichia coli. International journal of antimicrobial agents, 2002, Volume: 19, Issue:1 Topics: Anti-Infective Agents; Bacterial Adhesion; Cell Line; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Female; Hemagglutination; Humans; Inhibitory Concentration 50; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Urinary Tract Infections	2002